Adjuvants and Autoimmunity: Why Do We Develop Autoantibodies, Autoimmune Diseases and Lymphomas

Isr Med Assoc J. 2017 Jul;19(7):403-405.

Authors

Nicola Bragazzi¹, Abdulla Watad^{2

3

4}, Mohammad Adawi⁵, Howard Amital^{2

3

4}, Gali Aljadeff², Yehuda Shoenfeld^{2

4}

Affiliations

¹ Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
² Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
³ Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel.
⁴ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁵ Padeh and Ziv hospitals, Bar-Ilan Faculty of Medicine, Israel.

PMID: 28786252

No abstract available

Publication types

Editorial

MeSH terms

Adjuvants, Immunologic*
Autoantibodies / metabolism*
Autoimmune Diseases / etiology*
Autoimmune Diseases / immunology
Autoimmunity
Humans
Lymphoma / etiology*
Lymphoma / immunology

Substances

Adjuvants, Immunologic
Autoantibodies